114 related articles for article (PubMed ID: 38088366)
1. Epidemiology, Comorbidities, and Treatment of Cyclic Vomiting Syndrome in the United States.
Chen YJ; Princic N; Winer I; Richmond C; Williams J; Thavamani A; Levinthal DJ; Venkatesan T
Am J Gastroenterol; 2024 May; 119(5):965-976. PubMed ID: 38088366
[TBL] [Abstract][Full Text] [Related]
2. Clinical Characteristics, Comorbidities and Hospital Outcomes in Hospitalizations with Cyclic Vomiting Syndrome: A Nationwide Analysis.
Bhandari S; Venkatesan T
Dig Dis Sci; 2017 Aug; 62(8):2035-2044. PubMed ID: 28050780
[TBL] [Abstract][Full Text] [Related]
3. Incidence and prevalence of idiopathic inflammatory myopathies among commercially insured, Medicare supplemental insured, and Medicaid enrolled populations: an administrative claims analysis.
Smoyer-Tomic KE; Amato AA; Fernandes AW
BMC Musculoskelet Disord; 2012 Jun; 13():103. PubMed ID: 22703603
[TBL] [Abstract][Full Text] [Related]
4. Disease burden and cost of hidradenitis suppurativa: a retrospective examination of US administrative claims data.
Marvel J; Vlahiotis A; Sainski-Nguyen A; Willson T; Kimball A
BMJ Open; 2019 Sep; 9(9):e030579. PubMed ID: 31575575
[TBL] [Abstract][Full Text] [Related]
5. Incremental value of using Medicaid claim files to study comorbid conditions and treatments in dually eligible beneficiaries.
Bradley CJ; Dahman B; Bataki PM; Koroukian S
Med Care; 2010 Jan; 48(1):79-84. PubMed ID: 20050352
[TBL] [Abstract][Full Text] [Related]
6. Descriptive epidemiology of epilepsy in the U.S. population: A different approach.
Helmers SL; Thurman DJ; Durgin TL; Pai AK; Faught E
Epilepsia; 2015 Jun; 56(6):942-8. PubMed ID: 25921003
[TBL] [Abstract][Full Text] [Related]
7. Annual prevalence of diagnosed schizophrenia in the USA: a claims data analysis approach.
Wu EQ; Shi L; Birnbaum H; Hudson T; Kessler R
Psychol Med; 2006 Nov; 36(11):1535-40. PubMed ID: 16907994
[TBL] [Abstract][Full Text] [Related]
8. Health Care Burden Associated with Outpatient Opioid Use Following Inpatient or Outpatient Surgery.
Brummett CM; England C; Evans-Shields J; Kong AM; Lew CR; Henriques C; Zimmerman NM; Pawasauskas J; Oderda G
J Manag Care Spec Pharm; 2019 Sep; 25(9):973-983. PubMed ID: 31313621
[TBL] [Abstract][Full Text] [Related]
9. Clinical and economic characterization of mild, moderate, and severe systemic lupus erythematosus: Real-world observation across payer channels in the United States.
Wu SS; Perry A; Tkacz J; Bryant G
J Manag Care Spec Pharm; 2023 Sep; 29(9):1010-1020. PubMed ID: 37610115
[No Abstract] [Full Text] [Related]
10. Prevalence and incidence of cyclic vomiting syndrome in Japan: A study using Japanese claims data.
Chang CH; Hikita T; Takabayashi N; Sakaguchi M
PLoS One; 2022; 17(12):e0279502. PubMed ID: 36548340
[TBL] [Abstract][Full Text] [Related]
11. Incidence and prevalence of acromegaly in a large US health plan database.
Burton T; Le Nestour E; Neary M; Ludlam WH
Pituitary; 2016 Jun; 19(3):262-7. PubMed ID: 26792654
[TBL] [Abstract][Full Text] [Related]
12. Actuarial analysis of private payer administrative claims data for women with endometriosis.
Mirkin D; Murphy-Barron C; Iwasaki K
J Manag Care Pharm; 2007 Apr; 13(3):262-72. PubMed ID: 17407392
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology, Clinical Characteristics, and Associations for Rome IV Functional Nausea and Vomiting Disorders in Adults.
Aziz I; Palsson OS; Whitehead WE; Sperber AD; Simrén M; Törnblom H
Clin Gastroenterol Hepatol; 2019 Apr; 17(5):878-886. PubMed ID: 29857155
[TBL] [Abstract][Full Text] [Related]
14. Incidence rates of thrombosis with thrombocytopenia syndrome (TTS) among adults in United States commercial and Medicare claims databases, 2017-2020.
Lloyd PC; Lufkin B; Moll K; Ogilvie RP; McMahill-Walraven CN; Beachler DC; Kelman JA; Shi X; Hobbi S; Amend KL; Djibo DA; Shangguan S; Shoaibi A; Sheng M; Secora A; Zhou CK; Kowarski L; Chillarige Y; Forshee RA; Anderson SA; Muthuri S; Seeger JD; Kline A; Reich C; MaCurdy T; Wong HL
Vaccine; 2024 Mar; 42(8):2004-2010. PubMed ID: 38388240
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of Amyotrophic Lateral Sclerosis - United States, 2012-2013.
Mehta P; Kaye W; Bryan L; Larson T; Copeland T; Wu J; Muravov O; Horton K
MMWR Surveill Summ; 2016 Aug; 65(8):1-12. PubMed ID: 27490513
[TBL] [Abstract][Full Text] [Related]
16. Increased health care costs associated with new persistent opioid use after major surgery in opioid-naive patients.
Brummett CM; Evans-Shields J; England C; Kong AM; Lew CR; Henriques C; Zimmerman NM; Sun EC
J Manag Care Spec Pharm; 2021 Jun; 27(6):760-771. PubMed ID: 33624534
[No Abstract] [Full Text] [Related]
17. Characteristics and treatment patterns of US commercially insured and Medicaid patients with opioid dependence or abuse.
Wollschlaeger BA; Willson TM; Montejano LB; Ronquest NA; Nadipelli VR
J Opioid Manag; 2017; 13(4):207-220. PubMed ID: 28953313
[TBL] [Abstract][Full Text] [Related]
18. Health Care Resource Use, Costs, and Diagnosis Patterns in Patients With Schizophrenia and Bipolar Disorder: Real-world Evidence From US Claims Databases.
Broder MS; Greene M; Chang E; Hartry A; Touya M; Munday J; Yan T
Clin Ther; 2018 Oct; 40(10):1670-1682. PubMed ID: 30193748
[TBL] [Abstract][Full Text] [Related]
19. Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer.
Edwards BK; Noone AM; Mariotto AB; Simard EP; Boscoe FP; Henley SJ; Jemal A; Cho H; Anderson RN; Kohler BA; Eheman CR; Ward EM
Cancer; 2014 May; 120(9):1290-314. PubMed ID: 24343171
[TBL] [Abstract][Full Text] [Related]
20. Incremental Health Care Burden of Treatment-Resistant Depression Among Commercial, Medicaid, and Medicare Payers.
Shrestha A; Roach M; Joshi K; Sheehan JJ; Goutam P; Everson K; Heerlein K; Jena AB
Psychiatr Serv; 2020 Jun; 71(6):593-601. PubMed ID: 32237982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
